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Abstract
Background: There is considerable interest in dairy products from low-input systems, such as mountain-pasture
grazing cows, because these products are believed to be healthier than products from high-input conventional
systems. This may be due to a higher content of bioactive components, such as phytanic acid, a PPAR-agonist
derived from chlorophyll. However, the effects of such products on human health have been poorly investigated.
Objective: To compare the effect of milk-fat from mountain-pasture grazing cows (G) and conventionally fed cows
(C) on risk markers of the metabolic syndrome.
Design: In a double-blind, randomized, 12-week, parallel intervention study, 38 healthy subjects replaced part of
their habitual dietary fat intake with 39 g fat from test butter made from milk from mountain-pasture grazing cows
or from cows fed conventional winter fodder. Glucose-tolerance and circulating risk markers were analysed before
and after the intervention.
Results: No differences in blood lipids, lipoproteins, hsCRP, insulin, glucose or glucose-tolerance were observed.
Interestingly, strong correlations between phytanic acid at baseline and total (P<0.0001) and LDL cholesterol
(P=0.0001) were observed.
Conclusions: Lack of effects on blood lipids and inflammation indicates that dairy products from mountain-pasture
grazing cows are not healthier than products from high-input conventional systems. Considering the strong
correlation between LDL cholesterol and phytanic acid at baseline, it may be suggested that phytanic acid
increases total and LDL cholesterol.
Trial registration: ClinicalTrials.gov, NCT01343589
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Background
Increased consumer awareness of the link between diet
and health has led to research focused on altering the
fatty acid (FA) composition of cows’ milk to achieve a
FA profile consistent with public health recommenda-
tions. However, as modification of the FA content of
milk fat in dairy cows is affected significantly by the ex-
tensive metabolism of lipids that occurs in the rumen, it
is important to understand the interrelationship between
dietary supply of lipids, rumen fermentation, and mam-
mary synthesis of milk fat. Important targets include re-
ducing the amount of long-chain saturated fatty acids
(SFA’s) such as C12:0-C16:0, enhancing oleic acid to re-
duce cardiovascular risk, and generally increasing con-
centrations of mono- and poly-unsaturated fatty acid
(MUFA and PUFA) [1-10].
It is well known that the FA composition of milk fat is
markedly influenced by the feed given to the dairy cows
[11-14]. The addition of forage, especially fresh grass, to
fodder has been found to enhance the proportion of un-
saturated FAs in milk fat [15-17], and to elevate the con-
centration of the c-9, t-11 isomer of conjugated linoleic
acid (CLA) [17,18]. Unlike the c-10, t-12 isomer of CLA,
which in animal models has proved to be a biologically
active FA with beneficial effects on diseases such as can-
cer, diabetes, and obesity [19-21], the c-9, t-11 CLA ap-
pears to be neutral [22-27]. However, the markedly
higher intake of chlorophyll-containing green fodder in
grazing cows also results in a high phytanic acid content
in milk from these cows [28,29]. Phytanic acid may be
an interesting, though so far overlooked, bioactive FA
with potential positive effects on metabolic function.
Phytanic acid (3,7,11,15-tetramethyl hexadecanoic acid)
is a multi-branched FA with reported retinoid X receptor
(RXR) and peroxisome proliferator activated receptor-α
(PPAR-α) agonist activity [30-33]. It has been suggested
that, due to its reported RXR and PPAR-α agonist
activity and its ability to induce glucose uptake in he-
patocytes, phytanic acid may prevent metabolic dys-
functions related to the development of metabolic
syndrome [34].
The purpose of this study was to investigate the effects
on risk markers of cardiovascular diseases (CVD) and
type-2 diabetes in healthy humans of a diet containing
milk delivered from mountain-pasture grazing cows
from Norway (G) with that of a diet containing milk fat
of typical Danish composition (C). Although, modifica-
tion of the dairy cows’ diet has been extensively studied,
only very few human dietary intervention studies have
examined the effect of these modified dairy products on
CVD risk. In addition, the actual effects on human
health of milk from pasture-grazing cows and conven-
tional Danish milk have been poorly investigated. Since
no data exists on the effects of intake of phytanic acid in
a normal diet, we have also paid particular attention on
the potential effects of this FA.
Subjects and methods
Study design
We conducted a 12-week, controlled, double-blind, ran-
domized, parallel intervention study. Participants were
provided with the test diets that substituted part of their
daily diet and replaced approximately 15 percent of en-
ergy (E%) of their daily fat intake. Participants were
stratified according to baseline blood glucose level, gen-
der, and waist circumference, into two random treat-
ment groups receiving either the G diet or the C diet.
Subjects
Subjects ranged in the age from 50 to 70 years old, and
were recruited for the study through ads placed in local
newspapers. The baseline characteristics of the 38 sub-
jects who completed the study are given in Table 1. Ex-
clusion criteria were: BMI > 35 kg/m2, current or
previous chronic disease, regular use of medication, or
drug and alcohol abuse. All participants were apparently
healthy as indicated by a medical and lifestyle question-
naire. They all agreed to refrain from taking any dietary
supplements, from donating blood two months before
and during the study, and from taking any medication
that might interfere with study measurements. All sub-
jects were instructed to maintain the same level of phys-
ical activity throughout the study. Subjects completed a
three-day dietary record in order to provide information
about dietary intake during the intervention. This was
done before the intervention and after six weeks of
intervention. We found it relevant to evaluate the diet
after six weeks to gain information about dietary intake
during the intervention. Two weekdays and one Satur-
day/Sunday were included in the dietary record to take
into account any differences in nutrient intake during
weekdays and the weekend. After they had delivered
their first dietary record, participants were given feed-
back and advice on how they could decrease fat intake
during the intervention period. This was achieved by
guidance from our dietician. Collection of the test food
as well as follow-up and weighing every second week
took place at Department of Nutrition, Exercise and
Sports. The subjects were also weighed before and after
the intervention. In the event of weight gain, the partici-
pants were weighed each week and received advice from
our dietician on how to maintain a stable weight. After
four and eight weeks of intervention, the participants
were interviewed about their well-being, physical activity
level and diet to make sure they were adhering to the
test diet and maintained the same weight and physical
activity level. In addition, participants were supplied with
recipes to provide inspiration on how the test diet could
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be consumed. To keep track of compliance with, and
potential deviations from, the study guidelines, subjects
were asked to keep a log book in which they recorded
on a daily basis any illness, unusual activities, and failure
to consume the test diet.
Dietary intake was estimated using Dankost 3000 dietary
assessment software (Dankost, Copenhagen, Denmark).
Mean habitual energy intakes before the intervention were
8.6 MJ/d (range: 5.6-15.8 MJ/d); 33.5% (24.2-48.2%) of en-
ergy was from fat; 16.3% (11.6-22.8%) was from protein;
and 45.7% (30–58.3%) was from carbohydrates. Carbohy-
drate intake in the G group (43.86 ± 5.47 E%) was
reported to be lower than in the C group (47.84 ± 5.27
E%) (p=0.029) when expressed as E%, but not when
expressed as g/d. There were no other differences in ha-
bitual dietary intake between the two groups. The proto-
col and aims of the study were fully explained (orally
and in writing) to the participants, who subsequently
gave written informed consent. The Scientific Ethics
Committee for Copenhagen and Frederiksberg approved
the research protocol (H-B-2009-052).
Production of test milk
Milk fat for the human study was derived from milk
from pasture-grazing cows (Norwegian red cattle breed)
or conventionally fed Danish cows (Holstein-Friesian
breed). The two types of milk produced differed in FA
composition. The markedly higher intake of chlorophyll-
containing green fodder of the grazing cows resulted in
a high phytanic acid content in milk compared with the
conventional Danish milk. The milk from grazing cows
was produced by 104 cows from seven farms. It was col-
lected in August late in the grazing-season, as it was
assumed that the effects of grazing would be strongest
when the cows had been grazing all summer. The con-
ventional Danish milk was provided by Arla Food amba
(Viby J, Denmark) and originated from 47 farms. It was
collected in October when the cows were kept indoors
and fed conventional winter fodder. Cattle feeding rou-
tines were traditional, and farmers selected fodder ingre-
dients and made their own mixtures. Conventional
Danish milk cattle fodder consists of a mixture of corn
silage (35%), wheat-barley silage (25%), clover grass sil-
age (20%), soybean meal or rapeseed cake (10%), and a
small proportion of molasses or beet pellets, straw, vita-
mins and minerals. Milk from the grazing cows was
transported to Tine BA (Oslo, Norway) where the fat
was processed into butter.
Diets and test fats
The test butter had different FA compositions (Table 2).
The cholesterol-raising saturated fatty acids, lauric, myr-
istic and palmitic acid, constituted 20% less of the total
FAs in the G butter than the C butter (C12:0; C14:0 and
C:16:0) (36.4 vs. 45.4 wt%). The G butter also had a 26%
higher content of stearic acid (C18:0) (15.1 vs. 11.1 wt%),
32% higher content of trans-vacceninc acid (C18:1 t-11)
(2.5 vs. 1.7 wt%), 17% higher content of oleic acid (C18:1
c-9) (25.8 vs. 21.5 wt%), and 33% higher content of α-
linolenic acid (C18:3 n-3) (0.9 vs. 0.6 wt%) compared
with C butter. Furthermore, the n-6/n-3 ratio was 45%
lower in the G butter (2.9 vs. 1.6 wt%) compared with C
butter. The butter was incorporated into buns. The buns
were made in one batch and provided by the Depart-
ment of Nutrition, Exercise and Sports in Copenhagen.
During the intervention period, subjects were requested
Table 1 Baseline characteristics for the 38 healthy subjects participating in the 12 week intervention1
Grazing (n=20) Conventional (n=18)
Women, (n, %) 13, 65% 10, 55.6%
Age, (y) 61.9 ± 4.9 (52–69) 60.7 ± 5.9 (50–69)
Height, (cm) 170.5 ± 8.4 (158–187) 173.2 ± 7.5 (159.8-188)
Weight, (kg) 73.6 ± 8.4 (56.3-93) 79.9 ± 15.5 (61.35-122.6)
BMI, (kg/m2) 25.4 ± 2.7 (20.81- 30.55) 26.5 ± 3.6 (21.22-34.69)
Total cholesterol, (mmol/L) 5.8 ± 1.15 (3.95-7.53) 5.5 ± 0.86 (3.98-7)
LDL cholesterol, (mmol/L) 3.3 ± 0.83 (1.46-4.53) 3.3 ± 0.59 (2.45-4.21)
HDL cholesterol, (mmol/L) 1.5 ± 0.29 (1.02-2.06) 1.3 ± 0.31 (0.75-1.73)
Triacylglycerol, (mmol/L) 1.2 ± 0.46 (0.76-2.62) 1.3 ±0.59 (0.73-2.74)
hsCRP, (mg/L) 1.2 ± 1.46 (0.05-5.42) 1.0 ± 0.93 (0.05-3.11)
Insulin, (pmol/L) 30.6 ± 20.05 (7.2-90.75) 41.4 ± 35.04 (7.2-127)
C-peptide, (pmol/L) 566.2 ± 224.03 (349.5-1065.5) 611.8 ± 287.82 (298–1299.5)
Glucose, (mmol/L) 5.6 ± 0.51 (5.02-7.14) 5.7 ± 0.47 (5.14-6.57)
Phytanic acid, (μM) 3.0 ± 0.69 (1.98-4.76) 3.0 ± 0.61 (2.3-4.28)
1 Values are mean ± SD; range in parentheses. hsCPR high sensitive C-reactive protein, Grazing milk from grazing cows, Conventional milk from conventionally
fed cows.
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to replace part of their daily diet with three buns. The
buns contained 3.5 MJ of energy, with 7.5 E% from pro-
tein, 56 E% from carbohydrates, and 36.4 E% from fat.
All buns contained 13 g of butter, which yielded a fat in-
take from the test diet of 39 g a day (15 MJ).
Compliance
We used the concentration of pentadecanoic acid (C15:0)
in plasma as an indicator of milk fat intake, and thus of
compliance, because C15:0 in serum is considered as a
valid marker for intake of milk fat in humans [35-37]. In
addition, dietary records and log books were used to
reinforce the dietary advice and strengthen compliance,
and the results of the last records were used in the calcula-
tion of dietary changes during the study. A participant was
considered compliant when > 90% of the supplied buns
had been eaten.
Blood sampling and analysis
Blood samples were taken in duplicates on two consecu-
tive days, before the intervention period and at the end
of the intervention, from fasting subjects after 10 mi-
nutes of supine rest. The values from each sample set
were averaged. In addition to fasting for 12 hours, par-
ticipants were asked to refrain from smoking 12 hours
prior to the blood sampling and to refrain from
performing any extreme sport 36 hours prior to taking
the sample. Furthermore, they were asked not to drink
alcohol or take medicine 24 hours prior to the blood
sampling. Blood for FA analysis was collected in tubes
containing EDTA, which were kept on ice, and the sam-
ples were centrifuged at 4°C and 2200 × g for 15 min.
All samples were stored at −80°C until they were
analysed. All samples were analyzed at the Department
of Human Nutrition, except the FA analyses, which were
performed at the Technical University of Denmark.
Blood lipids
We assessed serum LDL and HDL cholesterol by en-
zymatic colorimetric procedure (ABX Pentra LDL Direct
CP and ABX Pentra HDL Direct CP respectively) on
ABX Pentra 400 Chemistry Analyzer (HORIBA ABX,
Montpellier, France). Total cholesterol was assessed and
analyzed by enzymatic photometric procedure (CHOD-
PAP from ABX Pentra Cholesterol CP) on ABX Pentra
400 Chemistry Analyzer (HORIBA ABX, Montpellier,
France). The concentration of triacylglycerol (TAG) was
assessed and analyzed by enzymatic colorimetric proced-
ure (ABX Pentra Triglycerides CP) on ABX Pentra 400
Chemistry Analyzer (HORIBA ABX, Montpellier, France).
The inter assay coefficients of variation (CV%) for total,
LDL and HDL cholesterol, and TAG were 1.9%, 3.3%,
2.8% and 4.2%, respectively. Intra assay CV% for total,
LDL and HDL cholesterol, and TAG were 0.9%, 0.9%,
1.2% and 2.6% respectively.
Fatty acid analysis in lipids and test fats
Total lipids were extracted and analyzed from blood
plasma samples as described by Tholstrup et al. [38] but
using TAG C19:0 as an internal standard. For lipid-
extraction from the buns, three buns were homogenized
in a kitchen blender, and three samples were randomly
taken from the homogenate. The bun lipids were
extracted according to the method of Folch [39], while
preparation of fatty acid methyl esters (FAME) was
performed as described earlier [38]. The response factor
was calculated for methyl esters of phytanic acid and
short-chained fatty acid, based on the response of pal-
mitic acid methyl ester (C16:0). The butter FAME were
separated on a 60-m Supelco SP-2380 column (Sigma-
Aldrich AS, Brøndby, Denmark) in a HP 6890 gas Chro-
matograph (GC) in split mode using He as carrier gas.
Table 2 Fatty acid composition of the test butter from
mountain-pasture grazing cows and from conventionally
fed cows
% fatty acid of total fatty acid
Grazing Conventional
% wt
C4:0 1.0 0.8
C6:0 1.3 1.4
C8:0 1.0 1.1
C10:0 2.2 2.8
C12:0 2.6 3.4
C14:0 9.4 11.0
C14:1 0.7 1.0
C15:0 0.9 1.1
C16:0 24.4 31.0
C16:1 n-7 1.2 1.6
C20:0 (phytanic acid) 0.4 0.2
C17:0 0.6 0.5
C17:1 0.2 0.2
C18:0 15.1 11.1
C18:1 t-11 2.5 1.7
C18:1 n-9 25.8 21.5
C18:1 n-7 0.4 0.9
c-9 t-11 CLA 0.7 0.6
C18:2 n-6 1.5 1.8
C18:3 n-3 0.9 0.6
n-6:n-3 ration 1.6 2.9
Total SFA 58.9 64.4
Total UFA 33.9 30.0
Total MUFA 30.8 27.0
Total PUFA 3.2 3.0
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GC settings were: Injector temperature 260°C, split ratio
1:20, carrier flow 1.2 mL/min, detector temperature
300°C, air flow in detector 300,0 mL/min, hydrogen flow
35 mL/min. FAME were separated using a temperature
program starting at 50°C and gradually increasing it to
160°C at a rate of 15°C/min; this temperature was kept for
0 min, after which the temperature was increasedto 182°C
at a rate of 1°C/min. The temperature was then raised to
200°C at a rate of 10°C/min, and the oven was kept at
200°C for 15 min before the temperature was increased
to 225°C. The final temperature was kept for 12 min
(total runtime 61.97 min). FAME was identified with au-
thentic standards.
Hs-C-reactive protein
Blood for analysis of high sensitive C-reactive protein
(hsCRP) was collected into dry tubes; samples were sub-
sequently centrifuged at 2200 × g for 15 min at 20°C.
Serum was stored at −80°C until the samples were
analysed. The CRP concentrations were measured using
latex immunoturbidimetry (ABX Pentra CRP CP) on
ABX Pentra 400 Chemistry Analyzer (HORIBA ABX,
Montpellier, France). The detection limit was 0.1 mg/L.
The inter and intra assay CV% was 3.4% and 3.6%,
respectively.
Insulin, C-peptide and glucose
Blood for analysis of insulin and C-peptide was collected
in dry tubes, whereas the blood samples for glucose were
collected in tubes with fluoride citrate; for both serum
and plasma preparation the samples were centrifuged at
2200 × g for 15 min at 20°C after coagulation. The sam-
ples were stored at −80°C until analysis. Insulin and C-
peptide concentrations were measured in serum with a
chemiluminescent immunometric assay on DPC Immulite
1000 (Siemens Medical Solutions Diagnostics, USA). Glu-
cose concentrations were measured in plasma and ana-
lyzed by enzymatic colorimetric procedure (ABX Pentra
Glucose HK CP) on ABX Pentra 400 Clinical Chemistry
Analyzer (HORIBA ABX, Montpellier, France). The inter
assay CV% for insulin, C-peptid and glucose was 5.1%,
4.3% and 1.7%, respectively. The intra assay CV% for insu-
lin, C-peptid and glucose was 2.7%, 1.9% and 1.1%.
Oral glucose tolerance test
A standard 75 g OGTT was administered at baseline
and after 12 weeks of the study, with blood sampled for
glucose and C-peptide at 0, 15, 30, 60, 90, 120 and 180
minutes [40]. Three-hour C-peptide and glucose areas
under the curve (AUC) were calculated from the OGTT
data, in millimol per minute per liter for glucose, and
picomol per minute per liter for C-peptide. Glucose and
C-peptide AUCs are the sum of the area of each time
segment by C-peptide or glucose concentration. C-peptide
AUC is an approximate measure of C-peptide secretion in
response to a standard oral glucose load.
Statistical analysis
For both diet treatments, baseline characteristics were
summarized by means of averages, standard deviations
and minimum/maximum values. Pearson correlation co-
efficients with corresponding p values for testing
whether or not the correlation is 0 were calculated be-
tween baseline values. The outcome variables total chol-
esterol, LDL, HDL, TAG, hsCRP, insulin, C-peptide,
glucose and phytanic acid were analyzed using an ana-
lysis of covariance (ANCOVA) model including the
treatments (the explanatory variable of interest) and
adjusting for differences between groups by including
the baseline level as well as the relevant covariates age,
gender, smoker and weight, which may be possible con-
founders when evaluating blood parameters. The treat-
ment effect was evaluated by means of an F-test.
Treatment differences were reported in terms of esti-
mated mean levels with corresponding standard errors.
Analysis of the OGTT data was carried out using a lin-
ear mixed ANCOVA including the interaction between
time and diet treatment in order to assess if time modi-
fied the effect of the diets during the three-hour period
of OGTT. Period effects as well as covariates adjusting
for group differences in age and BMI were included in
the model. Random effects were included to capture
between-subject variation. The time course of the esti-
mated treatment effects for both diets was shown graphic-
ally with corresponding standard errors. An approximate
F-test was used to evaluate the diet-time interaction and,
if non-significant, another approximate F-test was used
to evaluate if there was a time-independent diet effect.
In addition, diet effects in glucose AUC and C-peptide
AUC were assessed using ANCOVA, adjusting for the
baseline AUC.
For all models validation was based on graphical as-
sessment of residual plots and normal probability plots.
In the event departures were detected, the outcome vari-
ables in question were transformed using the logarithm
transformation.
P values were evaluated at a 5% significant level. The
analyses were carried out using PROC MIXED proced-
ure in Statistical Analysis System (SAS), version 9.1 (SAS
Institute, Cary, NC).
Results
Compliance
There was no difference in plasma C15:0 after the inter-
vention, and the average increase in C15:0 from baseline
was around 20% in both groups, which indicates the
consumption of a similar amount of dairy products in
both groups during the intervention (data not shown).
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Counting the number of buns eaten showed a mean
compliance of 99.18 ± 1.98 % in all groups together and
of 99.37 ± 1.75 % and 98.96 ± 2.23 % in the G and C
group, respectively. The number of buns not eaten did
not differ between the groups (p=0.54).
Dietary intake and body weight
Both groups had a minor weight gain during the inter-
vention, (0.89 ± 1.39 and 0.93 ± 0.78 kg for G and C, re-
spectively), but the weight gain did not differ between
the groups when expressed either as kg body weight
(p=0.80) or BMI (p=0.55). A dietician evaluated all diet-
ary records. One record from the G group was incom-
plete and therefore excluded from the statistical analysis.
The energy and macronutrient content in the partici-
pants’ daily diet during the intervention were calculated
from the dietary records (Table 3). The distribution
(% energy) of protein (p=0.89), carbohydrates (p=0.69), and
total fat (p=0.40) did not differ between the two groups.
Blood samples
We found strong correlations between plasma phytanic
acid at baseline and both total (r2=0.42, p<0.0001) and
LDL cholesterol (r2=0.35, p=0.0001). The correlation be-
tween the known marker of dairy-fat intake, plasma
C15:0 and both total cholesterol and LDL cholesterol
was weaker (r2=0.14, p=0.02 and r2=0.11, p=0.04, respect-
ively), although there was a strong correlation between
plasma C15:0 and phytanic acid (r2=0.44, p<0.0001)
(Table 4).
TAG, hsCRP, insulin, glucose, C-peptide AUC, and
glucose AUC required logarithm transformation. No sig-
nificant differences were observed between G and C diet
in serum total cholesterol (p=0.38), LDL cholesterol
(p=0.55), HDL cholesterol (p=0.51), TAG (p=0.36), hsCRP
(p=0.54), insulin (p=0.60), C-peptide (p=0.91), plasma glu-
cose (p=0.63) or plasma phytanic acid (p=0.15) (Table 5).
Analysis of the OGTT data revealed neither a significant
treatment-time interaction nor a significant treatment
effect for glucose (p=0.52 and p=0.27, respectively) and for
C-peptid (p=0.43 and p=0.98, respectively) (Figure 1).
There was no significant difference between the AUCs for
either glucose (p=0.89) or C-peptide (p=0.65) after the test
diets (Figure 1).
There were no significant differences between groups
in the erythrocyte FA composition (data not shown).
Discussion
This study was designed to compare the effects of butter
produced from milk from mountain-pasture grazing
cows with conventional Danish butter on risk markers
of CVD and type-2 diabetes. There were no differences
between diets with regard to effect on the metabolic pa-
rameters or on hsCRP.
Despite the fact that the cholesterol-raising SFAs were
decreased with 20% (45.4 to 36.4 % of total FAs) in the
G diet, this did not lead to lower plasma total and LDL
cholesterol concentrations. This is in agreement with re-
sults from a study by Tholstrup et al. where the
cholesterol-raising SFAs, especially palmitic acid, was re-
placed with mainly oleic and stearic acid [41]. In con-
trast, Noakes et al. found that consumption of modified
dairy products produced through the substitution of
cholesterol-raising SFAs with oleic and linoleic acid, sig-
nificantly reduced total- and LDL cholesterol with 4.3%
and 5.3%, respectively [42]. This study reported a sub-
stantially higher change in PUFA (8 g/100 g FA), which
is known to lower plasma LDL cholesterol more than do
MUFA [43,44], and may be the main reason for the LDL
cholesterol lowering effect [42]. This is supported by an-
other study, which reported a decrease plasma total-and
LDL cholesterol by consuming a similar modified butter
with a high increase in PUFA (6.5 g/100 g FA) [45]. In
addition, a combination of a relatively lower SFA and
substantially higher linoleic and oleic acid in Noakes
et al. [42] compared with our study could explain why
the hypocholesterolemic effects of oleic and linoleic acid
were successfully “expressed”.
A minor increase in ruminant trans FA (rTFA) was a
side effect of manipulating the cattle fodder. A study by
Tholstrup et al. [46] observed that the consumption of
rTFA-enriched butter (3.6 g/d) lowered total and HDL
cholesterol by 6% and 9% respectively, compared with
butter low in rTFA and high in SFA. However, the au-
thors concluded that these effects may have been partly
attributable to the higher MUFA and lower SFA content
in the rTFA-enriched butter, rather than to the effects of
rTFA alone. Two recent clinical studies found an in-
crease in plasma LDL cholesterol in conjunction with
high daily rTFA intakes: 10–12 g/d, representing 3.6-5%
of energy [47,48]. However, an intake of 10–12 g/d
rTFA/d is very high in practical terms. The concentra-
tion of rTFA in dairy products exists in quantities that
Table 3 Macronutrient intake after 6 weeks of the
intervention diet1
% of energy Grazing (n=19) Conventional (n=18)
Protein 14.3 ± 0.4 14.3 ± 0.4
Carbohydrates 47.5 ± 1.3 46.7 ± 1.3
Total Fat 34.0 ± 0.9 35.1 ± 0.9
Saturated FAs 16.0 ± 0.7 15.8 ± 0.7
Monounsaturated FAs 10.2 ± 0.4 10.6 ± 0.4
Polyunsaturated FAs 4.0 ± 0.2 3.6 ± 0.2
1 All values are estimated means ± SE. FAs Fatty acids, Grazing milk from
grazing cows, Conventional milk from conventionally fed cows. Values were
obtained from 3-day weighed food records. One dietary record was
incomplete and therefore excluded from the statistical analysis. No significant
differences between the two groups were found (ANCOVA).
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are too small to have any effect. Thus, it is unlikely that
the slight difference in trans FA in this study may have
affected the results.
The intake of fresh grass also slightly elevated the con-
centration of CLA in the G diet, as expected from earlier
studies [17,18]. CLA has been reported to reduce aortic
atherosclerosis in animal studies [49,50]. However, hu-
man study failed to find any effect of milk CLA on chol-
esterol. One study in which the CLA content was
enriched by rumen technology to provide 1.42 g/d of c-9,
t-11 CLA in dairy products failed to affect LDL cholesterol
level [27], which is in line with results from another study
with a daily intake of 4.22 g milk CLA [23]. In addition, it
is unlikely that the slight difference in CLA and the lower
concentration of CLA in the current study may have af-
fected the results.
The markedly higher intake of chlorophyll-containing
green fodder in grazing cows also resulted in a high
phytanic acid content in the milk. In a previous study
conducted by our group [51], we found a significant in-
crease in plasma phytanic acid in both groups, verifying
Table 4 Pearson’s correlations coefficients between baseline variables
Phyt HDL LDL Total CH Glucose Insulin hsCRP TAG C15:0
Phyt 1.0 0.24 0.61 0.651 0.16 0.01 0.28 0.29 0.671
HDL 1.0 0.25 0.544 −0.364 −0.454 −0.27 −0.464 0.11
LDL 1.0 0.934 −0.14 −0.11 0.16 0.21 0.342
Total CH 1.0 −0.16 −0.2 0.07 0.15 0.383
Glucose 1.0 0.404 0.494 0.591 0.414
Insulin 1.0 0.12 0.464 −0.03
hsCRP 1.0 0.464 0.364
TAG 1.0 0.334
C15:0 1.0
hsCRP high sensitive C-reactive protein, TAG Triacylglycerol, CH cholesterol, Phyt Phytanic acid.
C15:0, Plasma pentadecanoic acid. n = 38. 1 Significantly correlated P≤0.0001. 2 Significantly correlated P=0.04.
3 Significantly correlated P=0.02. 4 Significantly correlated P<0.05.
Table 5 Effects of the 12-week dietary intervention
Grazing (n=20) Conventional (n=18)
Total cholesterol, (mmol/L) 5.9 ± 0.10 5.8 ± 0.11
LDL cholesterol, (mmol/L) 3.4 ± 0.09 3.3 ± 0.09
HDL cholesterol, (mmol/L) 1.5 ± 0.04 1.4 ± 0.04
Triacylglycerol, (mmol/L) 1.2 ± 1.08 1.1 ± 1.09
hsCRP, (mg/L) 0.8 ± 1.36 0.6 ± 1.41
Insulin, (pmol/L) 32.0 ± 1.11 30.0 ± 1.12
C-peptide, (pmol/L) 586.1 ± 1.05 582.1 ± 1.05
Glucose, (mmol/L) 5.6 ± 1.01 5.7 ± 1.02
Phytanic acid, (μM) 3.6 ± 0.17 3.3 ± 0.18
All values are means ± SE. hsCRP high sensitive C-reactive protein, Grazing milk
from grazing cows, Conventional milk from conventionally fed cows. No
significant differences between the two diet groups were found (ANCOVA).
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Figure 1 Oral glucose tolerance test (OGTT) measurements
performed after 12 weeks of intervention. All values are
means ± SE. Grazing milk from grazing cows (n=20). Conventional
milk from conventionally fed cows (n=18). Glucose tolerance was
measured using a standard 75 g oral glucose-tolerance test. There
was no significant difference between areas under the curve (AUC).
There was no significant difference in the time course of glucose
and C-peptide concentration after the two different test fats or in
the mean glucose and C-peptide concentration according to the
repeated-measures analysis of variance.
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that intake of dairy products with relatively low concen-
trations of phytanic acid increase circulating phytanic
acid concentration. This finding seems to be in agree-
ment with observations made in this study. In the
present study we found surprisingly strong correlations
between phytanic acid at baseline, total cholesterol
(r2=0.42, p<0.0001) and LDL cholesterol (r2=0.35,
p=0.0001). It seems likely that the baseline phytanic acid
concentration reflects habitual dairy fat intake, which
means that the strong correlations could be due to the
hypercholesterolemic effect of dairy fat. This interpret-
ation is supported by the fact that plasma phytanic acid
and plasma C15:0 correspond very strongly at baseline
(r2=0.44, p<0.0001). However, the correlations between
plasma C15:0 and both total cholesterol (r2=0.14,
p=0.02) and LDL cholesterol (r2=0.11, p=0.04) were sub-
stantially weaker than those observed for phytanic acid.
This suggests that phytanic acid increases LDL choles-
terol beyond levels that can be explained solely from
dairy fat intake, indicating that phytanic acid may have
specific LDL cholesterol rising effects.
We observed no differences in effects on glucose or
insulin concentration between the groups. Prior to the
present study, the available literature supported the hy-
pothesis that phytanic acid might have preventive effects
on metabolic dysfunctions related to the development of
the metabolic syndrome [30-33]. In particular the RXR-
activating ability of phytanic acid is of interest, since
RXR is activated by concentrations at the same level as
the phytanic acid concentrations reached in plasma in
this study (21). It has been shown that drugs that acti-
vate RXR and PPAR-α have a marked impact on whole
body metabolism and act as insulin-sensitizers or as
hyperlipidemic agents [52,53], while it is not clear to
what extent dietary changes in natural agonist concen-
trations are of physiological importance in humans.
In the current study, milk fat from mountain-pasture
grazing cows which represents summer whole milk with
a SFA:MUFA:PUFA proportion of 59:31:3 was more
similar to conventional milk FA composition of 64:27:3
than predicted. In addition, the FA composition of con-
ventional milk FA in the current study was more con-
sistent with consumer perceptions of a healthy diet and
with public health recommendations compared to con-
ventional milk from 1998 with the composition of
75:22:4 [41]. This could be due to a higher amount of
grass-based products in the cows’ feed, and could ex-
plain why no effect is observed in the current study.
The strengths of our study include its controlled and
randomized design, the long intervention period, follow-
up of dietary compliance during the study, and the use
of a validated dietary marker to monitor the dairy-fat in-
take. The study was also designed to investigate dietary
changes caused by an increased intake of dairy products
in a realistic setting, and the plasma phytanic acid con-
centration in this study population occurred in a con-
centration which has physiological relevance as a
modulator of RXR-activity. Among the limitations were
the relatively high intakes of butter during the interven-
tion. Also breed of the cows may have played a role;
however there is no evidence that FA composition is dif-
ferently influenced by breed per se. The health effect of
milk from pasture grazing cows should be further inves-
tigated. Furthermore, it could be interesting to elucidate
the association between phytanic acid and the PPAR-α
activity to better prove the effects of phytanic acid on
plasma cholesterol.
Conclusion
Lack of effects on blood lipids and inflammation indi-
cates that dairy products from mountain-pasture grazing
cows are not healthier than products from high-input
conventional systems. Considering the strong correlation
between LDL cholesterol and phytanic acid at baseline,
it may be suggested that phytanic acid increases total
and LDL cholesterol. Additional studies are necessary to
clarify the effect of phytanic acid on risk markers of the
metabolic syndrome.
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